EXODIAB: Excellence of Diabetes Research in Sweden
61 – 70 of 4359
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Physical health in young males and risk of chronic musculoskeletal, cardiovascular, and respiratory diseases by middle age : A population-based cohort study
(
- Contribution to journal › Article
-
Mark
Deep Learning for Resolving 3D Microstructural Changes in the Fibrotic Liver
2025) International Conference on Medical Image Computing and Computer-Assisted Intervention - Applications of Medical Artificial Intelligence In Lecture Notes in Computer Science 15384. p.74-84(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Effect of broccoli sprout extract and baseline gut microbiota on fasting blood glucose in prediabetes : a randomized, placebo-controlled trial
2025) In Nature Microbiology(
- Contribution to journal › Article
-
Mark
Early Dietary Fiber Intake Reduces Celiac Disease Risk in Genetically Prone Children: Insights from the TEDDY study
2025) In Gastroenterology(
- Contribution to journal › Article
-
Mark
Alternative Complement Pathway in Carotid Atherosclerosis : Low Plasma Properdin Levels Associate With Long-Term Cardiovascular Mortality
(
- Contribution to journal › Article
-
Mark
Considerations for more actionable consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Reply to Mallone R [letter]
2025) In Diabetologia(
- Contribution to journal › Letter
-
Mark
Cognitive dysfunction in diabetes–the ‘forgotten’ diabetes complication : a narrative review
(
- Contribution to journal › Scientific review
-
Mark
Isolation and crystallization of copper resistance protein B (CopB) from Acinetobacter baumannii
(
- Contribution to journal › Scientific review
-
Mark
Complement Factor H Is an ICOS Ligand Modulating Tregs in the Glioma Microenvironment
(
- Contribution to journal › Article
-
Mark
Anti-viral action against type 1 diabetes autoimmunity : The GPPAD-AVAnT1A study protocol
(
- Contribution to journal › Article